[go: up one dir, main page]

IL122811A - Process for the optical purification of enantiomerically enriched benzimidazole derivatives - Google Patents

Process for the optical purification of enantiomerically enriched benzimidazole derivatives

Info

Publication number
IL122811A
IL122811A IL12281196A IL12281196A IL122811A IL 122811 A IL122811 A IL 122811A IL 12281196 A IL12281196 A IL 12281196A IL 12281196 A IL12281196 A IL 12281196A IL 122811 A IL122811 A IL 122811A
Authority
IL
Israel
Prior art keywords
enantiomerically enriched
benzimidazole derivatives
optical purification
enriched benzimidazole
purification
Prior art date
Application number
IL12281196A
Other languages
English (en)
Other versions
IL122811A0 (en
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20397468&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL122811(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IL122811A0 publication Critical patent/IL122811A0/xx
Publication of IL122811A publication Critical patent/IL122811A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL12281196A 1995-07-03 1996-06-26 Process for the optical purification of enantiomerically enriched benzimidazole derivatives IL122811A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9500817 1995-07-03
PCT/SE1996/000841 WO1997002261A1 (fr) 1995-07-03 1996-06-26 Procede de purification optique pour derives de benzimidazole enrichis par enantiomorphe

Publications (2)

Publication Number Publication Date
IL122811A0 IL122811A0 (en) 1998-08-16
IL122811A true IL122811A (en) 2000-11-21

Family

ID=20397468

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12281196A IL122811A (en) 1995-07-03 1996-06-26 Process for the optical purification of enantiomerically enriched benzimidazole derivatives

Country Status (36)

Country Link
US (1) US5929244A (fr)
EP (2) EP1498416A1 (fr)
JP (1) JP4195507B2 (fr)
KR (1) KR100451078B1 (fr)
CN (1) CN1098261C (fr)
AT (1) ATE418549T1 (fr)
AU (1) AU698638B2 (fr)
BR (1) BR9609450A (fr)
CA (1) CA2226184C (fr)
CZ (1) CZ295430B6 (fr)
DE (1) DE69637788D1 (fr)
DK (1) DK0836601T3 (fr)
DZ (1) DZ2057A1 (fr)
EE (1) EE03444B1 (fr)
ES (1) ES2318850T3 (fr)
HR (1) HRP960232A2 (fr)
HU (1) HUP9901717A3 (fr)
IL (1) IL122811A (fr)
IS (1) IS2666B (fr)
MA (1) MA23921A1 (fr)
MY (1) MY114018A (fr)
NO (1) NO313008B1 (fr)
NZ (1) NZ311842A (fr)
PL (1) PL186702B1 (fr)
PT (1) PT836601E (fr)
RS (1) RS49826B (fr)
RU (1) RU2144031C1 (fr)
SA (1) SA96170103B1 (fr)
SI (1) SI0836601T1 (fr)
SK (1) SK284780B6 (fr)
TN (1) TNSN96090A1 (fr)
TR (1) TR199701754T1 (fr)
TW (1) TW444010B (fr)
UA (1) UA49838C2 (fr)
WO (1) WO1997002261A1 (fr)
ZA (1) ZA965205B (fr)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP960232A2 (en) * 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
AU6551198A (en) * 1997-05-30 1998-12-30 Dr. Reddy's Research Foundation Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them
AU742620B2 (en) * 1998-01-30 2002-01-10 Sepracor, Inc. R-lansoprazole compositions and methods
SE9900274D0 (sv) 1999-01-28 1999-01-28 Astra Ab New compound
TWI275587B (en) 1999-06-17 2007-03-11 Takeda Chemical Industries Ltd A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
CA2375091A1 (fr) 1999-06-30 2001-01-11 Takeda Chemical Industries, Ltd. Cristaux de composes benzimidazole
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
EP1293507B1 (fr) 2000-05-15 2007-11-28 Takeda Pharmaceutical Company Limited Procede de production d'un cristal
ATE342263T1 (de) 2000-08-04 2006-11-15 Takeda Pharmaceutical Salze von benzimidazol-derivaten und deren verwendung
AU2002218506A1 (en) 2000-12-01 2002-06-11 Takeda Chemical Industries Ltd. Process for the crystallization of (r)- or (s)-lansoprazole
KR100433735B1 (ko) * 2001-06-27 2004-06-04 주식회사 씨트리 결정형 ⅰ을 갖는 란소프라졸의 제조방법
SE0104295D0 (sv) * 2001-12-18 2001-12-18 Astrazeneca Ab New process
JP2005521662A (ja) * 2002-01-25 2005-07-21 サンタラス インコーポレイティッド プロトンポンプ阻害剤の経粘膜送達
AU2003273000A1 (en) 2002-10-16 2004-05-04 Takeda Pharmaceutical Company Limited Stable solid preparations
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
DE10254167A1 (de) 2002-11-20 2004-06-09 Icon Genetics Ag Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen
ME00563A (en) 2002-12-06 2011-12-20 Process for preparing optically pure active compounds
BR0316702A (pt) 2002-12-06 2005-10-18 Altana Pharma Ag xprocesso para preparação de (s)-pantoprazol
WO2004073654A2 (fr) * 2003-02-20 2004-09-02 Santarus, Inc. Liberation immediate d'un complexe antacide d'omeprazole presentant une nouvelle formulation pour une elimination rapide et prolongee d'acide gastrique
BRPI0407906A (pt) * 2003-02-28 2006-02-14 Ranbaxy Lab Ltd polimorfos de s-omeprazol
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2531566C (fr) * 2003-07-18 2013-05-07 Santarus, Inc. Formulation pharmaceutique et procede de traitement de troubles gastro-intestinaux lies a l'acidite
US7005732B2 (en) * 2003-10-21 2006-02-28 Honeywell International Inc. Methods and systems for providing MEMS devices with a top cap and upper sense plate
FR2863609A1 (fr) * 2003-12-15 2005-06-17 Isochem Sa Procede d'enrichissement enantiomerique d'un melange d'enantiomeres d'alpha-aminoacides
SE0400410D0 (sv) * 2004-02-20 2004-02-20 Astrazeneca Ab New compounds
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2006009602A2 (fr) 2004-06-16 2006-01-26 Tap Pharmaceutical Products, Inc. Forme posologique a doses ppi multiples
FR2876101B1 (fr) * 2004-10-05 2007-03-02 Sidem Pharma Sa Sa Procede de preparation enantioselective de derives de sulfoxydes
EP1801110A1 (fr) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Sel d'arginine d'ésoméprazole
US7553857B2 (en) 2005-12-23 2009-06-30 Lek Pharmaceuticals D.D. S-omeprazole magnesium
US7786309B2 (en) * 2006-06-09 2010-08-31 Apotex Pharmachem Inc. Process for the preparation of esomeprazole and salts thereof
FR2909380B1 (fr) * 2006-12-04 2009-02-20 Sidem Pharma Sa Sa Conglomerats de sels de potassium de tenatoprazole
EP1947099A1 (fr) 2007-01-18 2008-07-23 LEK Pharmaceuticals D.D. Procédé pour l'élimination de solvant des sels d'oméprazole
KR101432866B1 (ko) * 2007-06-15 2014-08-26 엠큐어 파마슈티컬즈 리미티드 생활성 화합물의 설폭사이드화 방법
CN101323609B (zh) * 2007-06-15 2013-05-01 成都福瑞生物工程有限公司 不对称氧化硫醚成亚砜合成对映体含量高的苯并咪唑衍生物的方法
FR2920428B1 (fr) * 2007-08-29 2012-06-15 Univ Rouen Procede de dedoublement de sels de l'omeprazole
ES2638463T3 (es) 2008-03-10 2017-10-20 Takeda Pharmaceutical Company Limited Cristal de compuesto de bencimidazol
EP2346854A4 (fr) 2008-11-18 2012-10-17 Hetero Research Foundation Purification optique d esoméprazole
KR101001646B1 (ko) * 2008-12-12 2010-12-17 한미약품 주식회사 (ｒ)-(+)-란소프라졸의 제조방법 및 이에 사용되는 중간체
WO2011004387A2 (fr) 2009-06-18 2011-01-13 Matrix Laboratories Ltd Procédé de préparation de formes polymorphes du dexlansoprazole
WO2011058569A1 (fr) 2009-11-12 2011-05-19 Hetero Research Foundation Procédé de dédoublement de l'oméprazole
US20130197232A1 (en) 2010-01-29 2013-08-01 Ranbaxy Laboratories Limited Process for the preparation of crystalline forms of dexlansoprazole
JP6574773B2 (ja) * 2014-07-30 2019-09-11 株式会社アエタスファルマ １，４−ベンゾチアゼピン−１−オキシド誘導体の光学異性体、及びそれを用いた医薬組成物
EP3064495B1 (fr) * 2015-03-06 2016-12-14 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Procédé amélioré pour la préparation de l'esomeprazole optiquement pure

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU4640985A (en) * 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
DE69011645T2 (de) * 1989-11-29 1995-01-12 Toa Eiyo Ltd Cycloheptenopyridinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Antiulkusmitteln.
DE4035455A1 (de) * 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
IS4232A (is) * 1993-12-06 1995-06-07 Astra Aktiebolag Súbstitúerað bensimidasól, aðferðir við framleiðslu þess og lyfjafræðileg notkun
HRP960232A2 (en) * 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds

Also Published As

Publication number Publication date
EP0836601A1 (fr) 1998-04-22
SA96170103B1 (ar) 2006-07-30
IS2666B (is) 2010-08-15
UA49838C2 (uk) 2002-10-15
WO1997002261A1 (fr) 1997-01-23
CZ421197A3 (cs) 1998-06-17
ATE418549T1 (de) 2009-01-15
MA23921A1 (fr) 1996-12-31
HRP960232A2 (en) 1998-02-28
RS49826B (sr) 2008-08-07
TNSN96090A1 (fr) 2005-03-15
DE69637788D1 (de) 2009-02-05
EP0836601B1 (fr) 2008-12-24
MX9800160A (es) 1998-03-31
PT836601E (pt) 2009-02-17
EE9700368A (et) 1998-06-15
HUP9901717A3 (en) 2002-03-28
ZA965205B (en) 1997-01-03
SI0836601T1 (sl) 2009-04-30
CN1193971A (zh) 1998-09-23
YU37696A (sh) 1999-03-04
DZ2057A1 (fr) 2002-10-20
EP1498416A1 (fr) 2005-01-19
JP4195507B2 (ja) 2008-12-10
KR19990028631A (ko) 1999-04-15
AU698638B2 (en) 1998-11-05
PL186702B1 (pl) 2004-02-27
NO313008B1 (no) 2002-07-29
PL324394A1 (en) 1998-05-25
CA2226184C (fr) 2008-08-05
NZ311842A (en) 1998-12-23
HUP9901717A2 (hu) 2000-04-28
ES2318850T3 (es) 2009-05-01
SK179397A3 (en) 1998-09-09
HK1010193A1 (en) 1999-06-17
CZ295430B6 (cs) 2005-08-17
NO976030L (no) 1998-02-09
IL122811A0 (en) 1998-08-16
KR100451078B1 (ko) 2004-11-16
JPH11508590A (ja) 1999-07-27
TW444010B (en) 2001-07-01
TR199701754T1 (xx) 1998-04-21
BR9609450A (pt) 1999-03-02
IS4638A (is) 1997-12-22
CA2226184A1 (fr) 1997-01-23
NO976030D0 (no) 1997-12-22
CN1098261C (zh) 2003-01-08
RU2144031C1 (ru) 2000-01-10
MY114018A (en) 2002-07-31
EE03444B1 (et) 2001-06-15
SK284780B6 (sk) 2005-11-03
DK0836601T3 (da) 2009-03-16
US5929244A (en) 1999-07-27
AU6324096A (en) 1997-02-05

Similar Documents

Publication Publication Date Title
IL122811A (en) Process for the optical purification of enantiomerically enriched benzimidazole derivatives
IL122339A (en) Optically active (s)-(+) enantiomers of 2-imidiazoline-5-thione derivatives
FI960278A0 (fi) Anataasititaanidioksidin valmistusmenetelmä
HUP9900110A3 (en) Novel process for the synthesis of omeprazole
EP0744431A3 (fr) Procédé pour la préparation de polyamide aromatique
ITMI951445A0 (it) Procedimento per la produzione di carbammati aromatici
NO970212D0 (no) Fremgangsmåte for fremstilling av enantiomerene av O-demetyltramadol
DE69423179D1 (de) Prozess zur Herstellung von optisch aktiven 2-Amino-1-phenylethanol Derivaten
IL124645A0 (en) Process for the production of 1, 2-bis (acyloxylates)
GR3032600T3 (en) Process for the production of imidazo-benzodiazepine derivatives
GB2294256B (en) Apparatus for the production of oxygen
EE03393B1 (et) Protsess enantiomeerselt puhta asetidiin-2-karboksüülhappe saamiseks
ZA963132B (en) Process for the preparation of pure enantiomers of 1-2-pyridyl)-2-cyclo-hexylethylamine.
DE69610747D1 (de) Verfahren zur Herstellung von hochreinem 2,4'-Dihydroxydiphenylsulfon
NO973835D0 (no) Fremgangsmåte for fremstilling av lorakarbefmonohydrat
FR2721312B1 (fr) Procédé de fabrication d'halogénoalcanols.
HK1024691A (en) Process for the production of enantiomerically enriched $i(n)-acylazetidine-2-carboxylic acids
SE9502381D0 (sv) Process for the production of enantiomerically-pure azetidine-2-carboxylic acid
EP0490407A3 (en) Process for the enzymatic separation of the optical isomers of tosyloxy-alkanols
EP0461531A3 (en) Process for the purification of 2-chloro-5-nitrobenzaldehyde or their acetals

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees